WHO stops hydroxychloroquine and HIV drug trials in patients with COVID-19: report

0
131
Facebook
Twitter
Pinterest
WhatsApp

WHO has reported a total of 212,326 new cases of coronavirus worldwide in 24 hours.

Geneva:

The World Health Organization on Saturday halted its trials on hydroxychloroquine, a drug against malaria, and on the combination of lopinavir / ritonavir, a drug against HIV, for the treatment of hospitalized patients COVID-19, after failing to reduce the death rate, Al Jazeera reported.

“These interim trial results show that hydroxychloroquine and lopinavir / ritonavir produce little or no reduction in the mortality of hospitalized COVID-19 patients compared to the standard of care. The investigators of the solidarity trials discontinue the trials with immediate effect, “said WHO. as saying in a statement.

The WHO added that this decision will now affect other studies where the drugs are used for out-of-hospital or prophylactic purposes.

Meanwhile, WHO has reported a total of 212,326 new cases of coronavirus worldwide in 24 hours.

The agency also said that 5,134 deaths had been reported in the past 24 hours, bringing the total death toll to 523,011.

The WHO declared the COVID-19 epidemic a pandemic on March 11.

(With the exception of the title, this story was not edited by GalacticGaming staff and is published from a syndicated feed.)

LEAVE A REPLY

Please enter your comment!
Please enter your name here